An experimental treatment, gantenerumab, failed to help people at high risk of memory loss from Alzheimer’s or those who were in the early phases of the disease, the manufacturer said Monday.
Related Posts
Arizona Gov. Hobbs speaks out against near-total abortion ban ruling
The Arizona Supreme Court ruled that a near-total
Can a ‘prescription’ for free fruits and vegetables improve health? Studies say yes.
Programs that distribute free fruits and vegetable